An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540)

Condition:   UrticariaIntervention:   Drug: DesloratadineSponsor:   Merck Sharp & Dohme Corp.Completed - verified April 2015

Source: ClinicalTrials.gov - November 19, 2008 Category: Research Source Type: clinical trials